# Puma Biotechnology, Inc.: Form 8-K, filed Sep 26, 2023

- Company: [Puma Biotechnology, Inc.](/companies/pbyi.md) (CIK 1401667)
- Form: 8-K
- Filed: 2023-09-26
- Accepted by EDGAR: Sep 26, 2023, 16:10 ET
- Period: 2023-09-26
- Accession: 0001437749-23-026766
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1401667/000143774923026766/pbyi20230925_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1401667/000143774923026766/

## Items reported

- Item 7.01: Regulation FD disclosure

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1401667/000143774923026766/pbyi20230925_8k.htm

Filed Sep 26, 2023.
Source: SEC EDGAR, the filing index for accession 0001437749-23-026766. Last ingested by Listed: Nov 5, 2026, 17:46 ET. No prices; not investment advice.